Eque-cel

· Nanjing IASO Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eque-cel, covering 2025-07-20 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]